178 related articles for article (PubMed ID: 32353589)
1. 18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism.
Yang M; Zhang M; Liu Q; Xu T; Huang T; Yao D; Wong CW; Liu J; Guan M
Pharmacol Res; 2020 Jul; 157():104840. PubMed ID: 32353589
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide modulates HNF4α activity imparting on hepatic metabolism.
Zhang M; Yang M; Wang N; Liu Q; Wang B; Huang T; Tong Y; Ming Y; Wong CW; Liu J; Yao D; Guan M
Mol Cell Endocrinol; 2020 Aug; 513():110867. PubMed ID: 32422400
[TBL] [Abstract][Full Text] [Related]
3. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
4. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression.
Nedumaran B; Hong S; Xie YB; Kim YH; Seo WY; Lee MW; Lee CH; Koo SH; Choi HS
J Biol Chem; 2009 Oct; 284(40):27511-23. PubMed ID: 19651776
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.
Li J; Inoue J; Choi JM; Nakamura S; Yan Z; Fushinobu S; Kamada H; Kato H; Hashidume T; Shimizu M; Sato R
J Biol Chem; 2015 Sep; 290(39):24021-35. PubMed ID: 26272613
[TBL] [Abstract][Full Text] [Related]
6. HNF4α contributes to glucose formation in aged rat hepatocytes.
Park EY; Lee CH; Lee EK; Kim JH; Cova A; Lee SK; Cho SC; Kwak CS; Song KY; Park SC; Jun HS; Kim KT
Exp Gerontol; 2013 Dec; 48(12):1518-25. PubMed ID: 24177414
[TBL] [Abstract][Full Text] [Related]
7. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor 4α regulates the expression of the murine pyruvate carboxylase gene through the HNF4-specific binding motif in its proximal promoter.
Chavalit T; Rojvirat P; Muangsawat S; Jitrapakdee S
Biochim Biophys Acta; 2013 Oct; 1829(10):987-99. PubMed ID: 23665043
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
11. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
Choi HE; Kim Y; Lee HJ; Cheon HG
Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
14. Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α-dependent very low-density lipoprotein.
Song Y; Wu W; Sheng L; Jiang B; Li X; Cai K
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22497. PubMed ID: 32220030
[TBL] [Abstract][Full Text] [Related]
15. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.
Lu H; Lei X; Winkler R; John S; Kumar D; Li W; Alnouti Y
Lipids Health Dis; 2022 May; 21(1):46. PubMed ID: 35614477
[TBL] [Abstract][Full Text] [Related]
17. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
18. Hepatic hepatocyte nuclear factor 4α is essential for maintaining triglyceride and cholesterol homeostasis.
Yin L; Ma H; Ge X; Edwards PA; Zhang Y
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):328-36. PubMed ID: 21071704
[TBL] [Abstract][Full Text] [Related]
19. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
20. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
